Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy.

Deletion of the murine survival of motor neuron gene (SMN) exon 7, the most frequent mutation found in spinal muscular atrophy (SMA) patients, directed to neurons but not to skeletal muscle, enabled generation of a mouse model of SMA providing evidence that motor neurons are the primary target of the gene defect. Moreover, the mutated SMN protein (SMNDeltaC15) is dramatically reduced in the motor neuron nuclei and causes a lack of gems associated with large aggregates of coilin, a coiled-body-specific protein. These results identify the lack of the nuclear targeting of SMN as the biochemical defect in SMA.

[1]  U. Monani,et al.  The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy. , 2000, Human molecular genetics.

[2]  B. Schrank,et al.  Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III. , 2000, Human molecular genetics.

[3]  Hung Li,et al.  A mouse model for spinal muscular atrophy , 2000, Nature Genetics.

[4]  C. Lorson,et al.  A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. Dreyfuss,et al.  A Novel Function for SMN, the Spinal Muscular Atrophy Disease Gene Product, in Pre-mRNA Splicing , 1998, Cell.

[6]  J. Melki,et al.  The role of the SMN gene in proximal spinal muscular atrophy. , 1998, Human molecular genetics.

[7]  I. Mattaj,et al.  Ribonucleoprotein assembly: Clues from spinal muscular atrophy , 1998, Current Biology.

[8]  P. Dollé,et al.  In situ hybridization with 35S-labeled probes for retinoid receptors. , 1998, Methods in molecular biology.

[9]  G. Dreyfuss,et al.  The SMN–SIP1 Complex Has an Essential Role in Spliceosomal snRNP Biogenesis , 1997, Cell.

[10]  A. Smith,et al.  Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Arnold Munnich,et al.  Correlation between severity and SMN protein level in spinal muscular atrophy , 1997, Nature Genetics.

[12]  Mark Turmaine,et al.  Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.

[13]  J. Nadeau,et al.  Cloning, characterization, and copy number of the murine survival motor neuron gene: homolog of the spinal muscular atrophy-determining gene. , 1997, Genome research.

[14]  A. Munnich,et al.  cDNA isolation, expression, and chromosomal localization of the mouse survival motor neuron gene (Smn). , 1997, Genomics.

[15]  P. Chambon,et al.  In vivo functional analysis of the Hoxa-1 3' retinoic acid response element (3'RARE). , 1997, Development.

[16]  G. Dreyfuss,et al.  A novel nuclear structure containing the survival of motor neurons protein. , 1996, The EMBO journal.

[17]  A. Munnich,et al.  Structure and organization of the human survival motor neurone (SMN) gene. , 1996, Genomics.

[18]  J. Warter,et al.  Constitutive muscular abnormalities in culture in spinal muscular atrophy , 1995, The Lancet.

[19]  J. Weissenbach,et al.  Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.

[20]  D. Le Paslier,et al.  De novo and inherited deletions of the 5q13 region in spinal muscular atrophies. , 1994, Science.

[21]  I. Raška,et al.  Human autoantibody to a novel protein of the nuclear coiled body: immunological characterization and cDNA cloning of p80-coilin , 1991, The Journal of experimental medicine.

[22]  M. Nerenberg,et al.  Transgenic mice expressing β-galactosidase in mature neurons under neuron-specific enolase promoter control , 1990, Neuron.

[23]  N. Henderson,et al.  Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Henderson,et al.  Extracts of muscle biopsies from patients with spinal muscular atrophies inhibit neurite outgrowth from spinal neurons , 1987, Neurology.

[25]  N. Sternberg,et al.  Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites. , 1981, Journal of molecular biology.

[26]  J. Pearn,et al.  Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy. , 1978, Journal of medical genetics.

[27]  P. K. Ko,et al.  Denervated skeletal muscle fibers develop discrete patches of high acetylcholine receptor density. , 1977, Science.

[28]  John H. Pearn.  TheGeneFrequency ofAcute Werdnig-Hoffmann Disease (SMAType1).A Total Population Survey inNorth-East England , 1973 .

[29]  B. Osuntokun,et al.  Infantile spinal muscular atrophy in Nigerians. , 1970, The African journal of medical sciences.